Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 426-790-0 | CAS number: 162208-27-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- repeated dose toxicity: oral
- Remarks:
- other: not specified
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- other: Body responsible for the test
- Title:
- Unnamed
- Year:
- 1 999
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: Annex V
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- Diethyl thiophosphoryl (Z)-(2-aminothiazol-4-yl)methoxyimino acetate
- EC Number:
- 426-790-0
- EC Name:
- Diethyl thiophosphoryl (Z)-(2-aminothiazol-4-yl)methoxyimino acetate
- Cas Number:
- 162208-27-7
- Molecular formula:
- Hill formula: C10 H16 N3 O5 P S2
- IUPAC Name:
- diethoxy(sulfanylidene)-lambda5-phosphanyl (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetate
Constituent 1
Test animals
- Species:
- other: Rats (Sprague-Dawley)
Administration / exposure
- Route of administration:
- oral: unspecified
- Vehicle:
- corn oil
- Details on oral exposure:
- Method of administration:
Gavage - Duration of treatment / exposure:
- Test duration: 28 days
- Frequency of treatment:
- Dosing regime: 7 days/week
- No. of animals per sex per dose:
- Male: 5 animals at 0 mg/kg bw/day
Male: 5 animals at 15 mg/kg bw/day
Male: 5 animals at 35 mg/kg bw/day
Male: 5 animals at 75 mg/kg bw/day
Female: 5 animals at 0 mg/kg bw/day
Female: 5 animals at 15 mg/kg bw/day
Female: 5 animals at 35 mg/kg bw/day
Female: 5 animals at 75 mg/kg bw/day
Results and discussion
Results of examinations
- Details on results:
- Clinical observations:
During week 4 of treatment, 4 males in the 75 mg/Kg/day
group were found dead or killed on humane grounds due to
their poor clinical condition.
Clinical findings were confined to the high dose level males
and were first noted on Day 27. The findings consisted of
body tremors observed among all surviving males at predose
and persisting for up to 4 hours after dosing in some
animals. In addition unsteady gait, reduced body tone,
salivation and low carriage were noted occurring in one or
two males predose, and persisted for up to 3 hours after
dosing in the worst affected animal, which was then found
dead 4 hours after dosing. On Day 28 one male exhibited body
tremors and low carriage immediately after dosing. A sudden
deterioration in clinical condition was observed for this
male and another male, characterised by body tremors,
unsteady gait, reduced body tone, salivation, wet urogenital
region, low carriage, convulsions, laboured respiration,
protruding and dark eyes.
These two animals were killed for human reasons.
Reduced body weight gain and food consumption were also
noted for these animals during Week 4 of the treatment.
The high dose level females did not exhibit any signs of a
reaction to treatment during the 4 week treatment period.
All animals receiving 15 or 35 mg/Kg/day showed no clinical
signs considered to be related to treatment with the test
substance during the 4 week treatment period.
Functional Observation Behaviour:
Treatment with the test substance was not associated with
any behavioural changes which were considered to be
indicative of neurotoxicity.
Laboratory findings:
Haematology:
Analysis of haematological parameters measured on Day 29 did
not reveal any changes that were considered to be
toxicologically significant.
Biochemistry:
Investigation performed on Day 29 revealed that the single
surviving male from the high dose level group had a slightly
increased albumin/globulin ratio, when compared to the
control and other treated groups. This was associated with a
slight reduction in the total protein for this animal, a
slightly lower GPT and calcium value and a marginally higher
potassium value. However, no similar trends were noted for
these values among the female treated groups or the
remaining treated male groups.
All other changes observed in the blood parameters of the
remaining animals were not considered to be treatment
related.
Effects in organs:
Organ weight assessment revealed an increase in absolute
thymus, epididymides and liver weight of 53%, 23% and 21%
respectively for the single surviving high dose male animal
over controls. However there were no differences from
control observed in the organ weights of the remaining
treated males or among the treated female groups.
Macroscopic findings were confined to the 4 male rats killed
in Week 4. A pale spleen was noted in 2 of the animals. A
pale spleen and dark lungs were noted in another and another
showed congested lungs and watery stomach.
Effect levels
open allclose all
- Dose descriptor:
- NOAEL
- Effect level:
- 35 mg/kg bw/day (nominal)
- Basis for effect level:
- other: original NCD unit is mg/kg/day.
- Dose descriptor:
- NOEL
- Effect level:
- 15 mg/kg bw/day (nominal)
- Basis for effect level:
- other: original NCD unit is mg/kg/day.
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- Classified as: Xn - harmful
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.